Close

nueva normalidad

Nucleocapsid Antibodies Appear to Be Long-Lasting After SARS-CoV-2 Infection

In a prospective, longitudinal study, N-antibodies peaked 90–100 days after infection and persisted for at least 500 days in most patients. The duration of antibody response after SARS-CoV-2 infection is not clearly established, although prior studies have estimated that antibodies produced after natural infection last from 3 to 6 months. […]

Read More

Omicron Breakthrough Cases Boost Protection, Studies Say

Vaccinated people who have a breakthrough case of Omicron will have better protection against COVID-19 variants than vaccinated people who receive a booster shot, two new studies show. The University of Washington, working with Vir Biotechnology of San Francisco, looked at blood samples of vaccinated people who had breakthrough cases of […]

Read More

Estrogen Treatment Linked to Reduced COVID Mortality

Women who went on hormone replacement therapy (HRT) with estrogen within six months of catching COVID-19 had a reduced risk of dying, a new study says. The study, coupled with data showing men have higher hospitalization and mortality rates from COVID than women, provides more evidence that estrogen may offer broad protection against the […]

Read More

Evaluación vacuna anti-COVID-19 en niños, manejo de gastroenteritis, y beneficios de la aplicación universal de la vacuna de varicela en México

En esta sección estarán disponibles los resúmenes de artículos recientes, publicados en las principales revistas científicas de pediatría, analizados por el Dr. Jesús Hernández. El Dr. Hernández Tiscareño es egresado de la Benemérita Universidad Autónoma de Puebla y de la Universidad Nacional Autónoma de México, donde cursó un posgrado en […]

Read More

Modifiable Risk Factors for Alzheimer Disease and Related Dementias Among Adults Aged ≥45 Years — United States, 2019

Summary What is already known about this topic? The 2021 National Plan to Address Alzheimer’s Disease (National Plan) included a goal to reduce the risk for Alzheimer disease and related dementias (ADRD). What is added by this report? Adults aged ≥45 years with subjective cognitive decline (SCD) were more likely […]

Read More

España prepara la compra de miles de vacunas contra la viruela tradicional para hacer frente al brote del virus del mono

El Ministerio de Sanidad prepara los trámites para comprar miles de dosis de una vacuna aprobada frente a la viruela tradicional que también es útil para frenar la transmisión del virus de la viruela del mono, frente al que en Europa no hay ningún suero específico aprobado, según han confirmado a EL […]

Read More

La FDA aprueba la primera dosis de recuerdo para los de 5 a 11 años

Con fecha 17 de mayo, la Food and Drug Administration de los Estados Unidos (FDA) ha concedido la autorizado de uso en emergencias de la vacuna Comirnaty en niños de cinco a once años, siempre que hayan transcurrido al menos cinco meses desde la recepción de las dosis de primovacunación con la […]

Read More

New White House COVID-19 Leader on What’s Next

Long before he was named the White House’s new COVID-19 czar, Ashish Jha, MD, acknowledged that US strategy to overcome the pandemic needed a new direction. Thanks to safe, effective vaccines, Jha reasoned, it was time to move on from the early goal of trying to prevent every SARS-CoV-2 infection […]

Read More
Translate »